On this page
The Case for Evidence-Based Stock Selection
Most investors begin with a total market index fund—a sensible, humble choice that buys everything and charges almost nothing. But what if the academic data suggested you could tilt that portfolio toward specific characteristics and capture an extra 3 to 4 percentage points of annual return over decades? That's the premise of factor investing: not stock-picking or market-timing, but systematic exposure to patterns that researchers have documented and validated across nearly a century of market history.
Factor investing emerged from academic finance, particularly from Nobel Prize-winning work by Eugene Fama and Kenneth French in 1992, demonstrating that stock returns weren't explained by broad market exposure alone. Their research revealed that two simple characteristics—size (smaller companies) and value (cheaper stocks)—accounted for a substantial portion of return variations. This discovery spawned decades of follow-up research identifying additional factors, from momentum to profitability to low volatility. Today, factor-tilted funds offer individual investors access to strategies once reserved for institutions.
But factor investing demands something many retail investors struggle to provide: patience measured in decades and the discipline to hold through multi-year droughts of underperformance.
Understanding the Four Core Factors
Value is the oldest and most heavily researched factor. Value stocks—typically defined by low price-to-book or price-to-earnings ratios—have historically outperformed their expensive growth counterparts by roughly 1 to 2 percentage points annually over 80+ year periods. Yet value experienced a brutal 13-year drought from 2007 to 2020, during which growth stocks dominated decisively. Many investors abandoned their value tilts during that period, only to miss the sharp rebound that followed. The intuition underlying value is straightforward: cheap companies are cheap for a reason (often because the market fears they'll stay distressed), but over time, mean reversion tends to occur. A company trading at half its historical average price-to-book ratio may eventually return to normal valuations, delivering outsize returns to patient holders.
Size (the small-cap premium) refers to the tendency of smaller companies to deliver higher returns than large-cap stocks over very long periods. From 1926 to 2021, small-caps returned 11.99% annually versus 10.35% for large-caps—roughly a 1.6 percentage point annual difference. However, this historical aggregate masks a lumpy distribution: essentially all of that premium came from a single nine-year window between 1975 and 1983, when small-caps surged over 1,400% following the collapse of the "Nifty Fifty" and ERISA-driven pension fund diversification. Over many other multi-decade stretches, small and large caps have returned nearly identically. Smaller companies trade less frequently, receive less analyst coverage, and carry higher business risk—the premium compensates for these friction costs and risks.
Small-cap value combines both factors and historically represents the most powerful combination: stocks that are both small and cheap. From 1927 through 2024, small-cap value portfolios delivered approximately 14 to 15% annualized returns compared to the broad market's 10% average. Yet this factor too has periods of acute underperformance; the 20-year relative return of small-cap value versus the S&P 500 recently dipped negative for the first time in U.S. history, prompting declarations that the premium had died. Historical precedent, however, suggests otherwise: in three previous periods (late 1990s, 1947, and 1965) when 20-year returns flattened, small-cap value recovered sharply within three years, jumping to 3+ percentage points of annualized outperformance.
Momentum differs fundamentally from value and size. It is a short-to-medium term phenomenon (3 to 12 months) where stocks with recent strong performance continue rising. Momentum premiums are sizable and robust across 150 years of global data, but momentum strategies carry the highest turnover costs and dramatic crash risk: they are vulnerable to sharp reversals during market regime shifts when yesterday's winners become today's losers overnight. The behavioral explanation for momentum is compelling—investors are slow to process good news, so stocks with strong recent fundamentals see prices lag reality before catching up—yet the practical cost of capturing momentum through active trading often erodes its theoretical advantage.
Quality and profitability factors favor companies with strong balance sheets, consistent earnings, and high returns on equity. They complement value nicely: a cheap stock is most attractive when it's cheap and financially healthy, not cheap because it's a potential bankruptcy. Vanguard's research on factor investing emphasizes that quality factors reduce volatility while maintaining return potential, making them attractive for conservative factor tilts.
How Factors Work in Practice: A Worked Example
Consider an investor named Marcus with $500,000 to deploy in March 2015. He splits his allocation into two approaches.
Approach 1: Total Market Index. Marcus buys a total market fund at 0.03% expense ratio. Over the next nine years through March 2024, the U.S. broad market (S&P 500 proxy) returned approximately 10.5% annualized. His $500,000 grows to roughly $1,195,000 (after fees).
Approach 2: Small-Cap Value Tilt. Marcus allocates $250,000 (50% of stocks) to broad market and $250,000 (50%) to a small-cap value factor fund charging 0.20% in fees. He believes the historical 3-4% annual small-cap value premium justifies the higher fee. From March 2015 to March 2024:
- Large-cap allocation ($250,000): grows at ~10.5% = ~$601,000
- Small-cap value allocation ($250,000): grows at ~13.5% (10.5% + 3% premium minus 0.20% fee) = ~$657,000
- Total portfolio: ~$1,258,000
Over nine years, the modest factor tilt added roughly $63,000 in additional wealth despite the higher fee. Annualized, Marcus captured an extra 0.63% annually—far less than the historical premium, but a real difference.
However, this cherry-picked period was favorable to value. Had Marcus implemented this strategy in 2010, he would have endured nine years of underperformance (2010-2019) before seeing the small-cap value bounce-back in 2020. Many investors would have abandoned the tilt by 2018, locking in losses before the recovery.
Costs, Fees, and Realistic Premiums
Factor funds from providers like Vanguard, iShares, Dimensional Fund Advisors, and Avantis typically charge 0.1% to 0.4% in annual expense ratios—10 to 13 times higher than a 0.03% total market fund. The SEC emphasizes that past performance does not predict future results, a reminder that factor premiums are not guaranteed; they are expected returns based on decades of historical data that may not persist uniformly.
The fee hurdle is real. If a factor premium is 1.5% annualized and the fund charges 0.3%, you net only 1.2%—and that's before taxation and the behavioral discipline required to hold. If the premium is 0.5%, you're underwater. The math works only for well-documented, sizable premiums—value and momentum, not exotic factors invented in recent academic papers.
When (and Why) Factors Disappoint
Vanguard's November 2023 research on factors notes plainly that "factor returns can be cyclical, so investors could experience sharp and lengthy periods of underperformance compared with the broader stock market." This is not a bug; it is the structure of factors.
International diversification within factors reveals the complexity. While U.S. small-cap value has underperformed for two decades, international developed markets showed a 2.7% small-cap value outperformance over the same 20 years, and emerging markets showed 4.0%. Geography matters. Time horizon matters more. A factor premium that vanishes for 13 years (value, 2007-2020) will reappear—but only if you remain invested through the entire period.
The Behavioral Discipline Required
Factor investing tests your psychological resolve in a way total market indexing does not. When small-cap value underperforms for three, five, even seven consecutive years, the case for staying the course feels absurd. Your total market friend's portfolio is outpacing yours. Articles declare the premium dead. Yet investors who fled factors during these valleys invariably bought back in near the peak of the recovery, crystallizing losses.
The SEC's guidance on diversification emphasizes the value of rebalancing—periodically selling your outperforming positions and buying your underperforming ones. Factor tilts make rebalancing harder because you must systematically buy more of the factor that is failing. This is the opposite of the momentum chase that ruins most retail investors; it is disciplined contrarianism.
A Practical Path Forward
Factor investing is not a shortcut to beating the market; it is an evidence-based framework for expressing a conviction about long-term return drivers. If you believe decades of academic research and have the patience to hold through 10-year underperformance periods, factor tilts may be worth the added cost and complexity. Start small—perhaps a 25% tilt rather than 50%—in factors with the strongest historical premiums (value and small-cap value) and lowest turnover costs. Use low-cost providers. Commit to a holding period of at least 20 years, ideally longer. Accept that factors will disappoint regularly and may never deliver their historical premiums at all.
For most investors, a simple total market index fund remains the smarter default. But for those willing to engage seriously with the evidence and hold their conviction through the inevitable valleys, factor investing offers a disciplined alternative grounded in nearly a century of market history.
